Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 February 2024 | Story VALENTINO NDABA | Photo SUPPLIED
Dr Jacques Matthee
Dr Jacques Matthee, was recently appointed the new Vice-Dean at the Faculty of Law.

In the dynamic landscape of academia, where traditional methodologies intersect with digital advancements, Dr Jacques Matthee stands out as a beacon of innovation and change. Recently assuming the role of Vice-Dean for Learning, Teaching, Innovation, and Digitalisation at the Faculty of Law, University of the Free State (UFS), Dr Matthee brings with him a profound dedication to knowledge, a passion for transformation, and a clear vision for the future of legal education.

With a distinguished academic background, including qualifications in LLB, LLM, and LLD, Dr Matthee has established himself as an expert in areas such as Legal Pluralism, African Customary Law, Criminal Law, and Medical Law. However, it is not just his credentials that distinguish him; it is his unwavering commitment to the pursuit of knowledge that sets him apart.

Pursuing knowledge: A lifelong passion

Reflecting on his childhood aspirations, Dr Matthee recalls dreaming of becoming a detective – a fascination that eventually led him to the realm of law. Over time, his interest in law deepened, propelling him towards his current position as a leading figure in legal academia. Yet, Dr Matthee’s ambitions extend beyond conventional success. In 2023, he surprised many by participating in his first-ever fitness event, demonstrating a determination to challenge himself beyond the boundaries of his profession. This blend of dedication, discipline, and integrity not only characterises his personal pursuits but also informs his professional endeavours.

Charting new horizons: The Vice-Dean's vision

Assuming the role of Vice-Dean for Learning, Teaching, Innovation, and Digitalisation, Dr Matthee enters uncharted territory. "It is a new position, not only within the faculty but also at UFS," he explains. "There is no model or blueprint to guide us." However, it is precisely this challenge that excites him the most. With autonomy in his role, Dr Matthee sees an opportunity to shape the future of legal education by pioneering initiatives that integrate traditional pedagogy with cutting-edge digital advancements.

"I look forward to the challenge of creating such a blueprint," Dr Matthee remarks. "Moreover, the position will allow me to explore and introduce exciting initiatives that could make a meaningful impact on the future and direction of teaching and learning in the faculty."

For Dr Matthee, the future of legal education lies not only in embracing innovation but also in cultivating an environment where curiosity thrives and knowledge knows no bounds. Under his leadership, the Faculty of Law at UFS is poised to embark on a transformative journey, where learning, teaching, and innovation converge to shape the legal minds of tomorrow.

In Dr Jacques Matthee, the UFS Faculty of Law finds not just a Vice-Dean, but a visionary dedicated to pushing boundaries, challenging norms, and sculpting a future where the pursuit of knowledge knows no limits. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept